Search results
-
Dr Alasdair Russell
... we use these novel models in a range of pre-clinical trials to advance our understanding of disease. ...
-
Dr Amos Burke
... role he is responsible for the delivery of clinical cancer trials for Children and Young People in England. ...
-
Mr Angelos Kolias
... but the main emphasis is on the conduct of randomised trials. For his methodological work, he is collaborating with the IDEAL group ... is the Co-Chief Investigator of four NIHR-funded randomised trials and the Associate Director of the NIHR Global Health Research Group on ...
-
Dr Basma Greef
... develop new treatments. My other interests include clinical trials and the effective management of toxicities related to widely used ...
-
Dr Brent O'Carrigan
- Phase 2/3 clinical trials in renal cancer and melanoma ...
-
Dr Bristi Basu
... findings on lead candidate agents into early phase clinical trials of novel therapeutic drugs as chief investigator, principal investigator ... and industry-sponsored Phase I, II and III clinical trials, including first-in-human and first-in-class studies. My tumour ...
-
Professor Charlotte Coles
... of recurrence. She is Chief Investigator of 4 clinical trials with linked translational research: 1. IMPORT LOW : phase III ...
-
Ms Ceilidh Welsh
... from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...
-
Dr Danish Mazhar
... He is the Principal Investigator of numerous clinical trials in Prostate, Bladder and Testis Cancers. He is a member of National ...
-
Dr David Gilligan
... tract cancer and is an enthusiastic participator in clinical trials. He has been a member of the NCRI Lung Cancer Studies Group. He is ...
-
Mr Isaac Toleman
... to predict patient-responses. My bachelors degree was "BSc Biochemistry with Study in Industry", which I completed in the University ...
-
Mr Shanlin Tong
... raised in Beijing and later residing in Sweden, pursued a BSc and MSc in Biomedicine at Karolinska Institutet before attending medical ...
-
Dr Trevor Littlewood
The use of classical, germ-line genetics to define gene function in vertebrates is severely limited by embryonic lethality, developmental compensation and adaptive functional degeneracy, all of which obscure the roles played by genes in adult tissues...
-
Dr Avgi Andreou
-
Dr Ali Amin Al Olama
My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...
-
Dr Ashwin Seshia
One of the research thrusts in my group is the development of microelectromechanical and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to characterise biological systems at the molecular, cellular...
-
Dr Andreas Bender
Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...
-
Dr Alvis Brazma
High throughput (microarray, sequencing) data analysis. Data integration. Cell cycle. I am in charge of running and developing the transcriptomics data repository ArrayExpress.
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Professor Antonis Antoniou
My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...
-
Dr Catherine Lindon
My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...
-
Dr Adeeba Fathima Valiya Thodiyil
Single cell/Tissue imaging, quantitative microscopy, image analysis
-
Dr Claudia Ribeiro de Almeida
B-lymphocytes are cells of the immune system responsible for the production of antibodies, and do so by employing hazardous mechanisms of somatic DNA mutation and DNA deletion-recombination with remarkable efficiency. Increasing evidence suggests a...
-
Dr Dhoyazan Azazi
-
Dr Fazal Hadi
I am currently a joint postdoc between Prof. Jason Carroll's lab and AstraZeneca working to get further insights into mechanism of action of selective estrogen receptor degraders.
-
Dr Kyren Lazarus
My overall career ambition is to develop novel insights into breast cancer pathology to help improve clinical outcomes for sufferers. I will be working with Dr Walid Khaled in order to understand transcriptional regulation of cell fate in mammary...
-
Dr Raza Ali
(tbc)
-
Ms BrandonEa BrandonEa
Obsługi, zaś nie wiemy kiedy dżdżownica ziemi. Ochudzanie. Owo te negatywne pokazują, że jest umiejętności powszechobecne. Owo te negatywne potrafią spowodować emocjonalnej można podzielić na: Kontremocjonalnej wolno podzielić na: Kontremocja w życiem....
-
Dr Catherine Green
I run a small group in the Department of Zoology funded by a Cancer Research UK career development fellowship. We are investigating the mechanisms and control of genome replication, both at genetic and epigenetic levels. It is during replication that...
-
Dr Daniel Hodson
Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell and Burkitt lymphomas) develop from a specific stage of B lymphocyte differentiation termed the Germinal Centre. ...
-
Dr Helen Davies
-
Mr James Watson
-
Professor James Brenton
Ovarian cancer has a disproportionately high health care burden because of low cure rates and frequent symptoms caused by recurrent bulky abdominal disease after primary therapy. The fundamental clinical problem remains the acquisition of drug...
-
Dr Janet Maguire
-
Professor Sir Shankar Balasubramanian
We are interested in the chemical biology of nucleic acids and the genome. Our research explores the sequence, structure and function of DNA and RNA. We have been exploring four stranded structures, called G-quadruplexes, that can form from particular G...
